AbCellera Biologics Cash from Financing (TTM) Insights

AbCellera Biologics Inc (ABCL)

3.78 +0.15 (+4.13%) USD | NASDAQ | Apr 26, 10:33

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	10.36M
September 30, 2023	6.94M
June 30, 2023	0.291M
March 31, 2023	1.045M
December 31, 2022	-1.628M
September 30, 2022	-0.143M
June 30, 2022	0.774M

Date	Value
March 31, 2022	-5.474M
December 31, 2021	-3.886M
September 30, 2021	604.22M
June 30, 2021	588.95M
March 31, 2021	594.37M
December 31, 2020	683.65M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-5.474M

Minimum

Mar 2022

683.65M

Maximum

Dec 2020

190.73M

Average

1.045M

Median

Mar 2023

Cash from Financing (TTM) Benchmarks